<DOC>
	<DOCNO>NCT00569413</DOCNO>
	<brief_summary>The current study combine molecular genetic perspective , self report brain imaging study human sexuality control subject individual sexual disorder clinic . The investigator hypothesize variability component brain dopaminergic system express mesolimbic reward system explain variability human sexuality , especially desire pleasure associate sex .</brief_summary>
	<brief_title>A Combined Psycho-pharmacological Brain Imaging Study Human Sexuality</brief_title>
	<detailed_description>We intend combine molecular genetics dopamine receptor ( D2 , D3 D4 D5 ) brain image use 11 C Raclopride Positron Emission Tomography ( PET ) . 11 C Raclopride ligand bind dopamine receptor D2 measure dopamine release pleasure anticipatory reward associate sex . The current proposal measure change DRD2 receptor occupancy use 11 C Raclopride follow explicit visual sexual desire cue healthy control subject individual suffer sexual dysfunction . This order determine individual genotype modulate dopamine release vivo human brain .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<criteria>Healthy volunteer patient Age 2165 Male female Psychiatric diagnosis/psychosis Neurological damage associate loss consciousness Infectious disease HIV Herpes Syphilis Hyperactivity treat ritalin Pregnant woman Under age</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Sex</keyword>
	<keyword>brain imaging</keyword>
	<keyword>dopamine</keyword>
	<keyword>sexual disorder</keyword>
</DOC>